Hospira Inc. reports sales for the quarter

LAKE FOREST- Hospira Inc., a global specialty pharmaceutical and medication delivery company, reported net sales for the quarter were $860 million, and adjusted diluted earnings per share were 60 cents. "Hospira delivered on its commitments in the first quarter, generating solid sales and earnings growth in a period marked by continued economic uncertainty," said Christopher B. Begley, chairman and chief executive officer. Net sales decreased 3.3 percent in the first quarter of 2009, compared to $889 million in the first quarter of 2008.